Publication

How to design a study to evaluate therapeutic drug monitoring in infectious diseases?

Märtson, A-G., Sturkenboom, M. G. G., Stojanova, J., Cattaneo, D., Hope, W., Marriott, D., Patanwala, A. E., Peloquin, C. A., Wicha, S. G., van der Werf, T. S., Tängdén, T., Roberts, J. A., Neely, M. N. & Alffenaar, J-W. C., Aug-2020, In : Clinical Microbiology and Infection. 26, 8, p. 1008-1016 9 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Copy link to clipboard

Documents

  • How to design a study to evaluate therapeutic drug monitoring in infectious diseases_ _ Elsevier Enhanced Reader

    Final publisher's version, 5.84 MB, PDF document

    Request copy

DOI

Background: Therapeutic drug monitoring (TDM) is a tool to personalize and optimize dosing by measuring the drug concentration and subsequently adjusting the dose to reach a target concentration or exposure. The evidence to support TDM is however often ranked as expert opinion. Limitations in study design and sample size have hampered definitive conclusions of the potential added value of TDM. Objectives: We aim to give expert opinion and discuss the main points and limitations of available data from antibiotic TDM trials and emphasize key elements for consideration in design of future clinical studies to quantify the benefits of TDM. Sources: The sources were peer-reviewed publications, guidelines and expert opinions from the field of TDM. Content: This review focuses on key aspects of antimicrobial TDM study design: describing the rationale for a TDM study, assessing the exposure of a drug, assessing susceptibility of pathogens and selecting appropriate clinical endpoints. Moreover we provide guidance on appropriate study design. Implications: This is an overview of different aspects relevant for the conduct of a TDM study. We believe that this paper will help researchers and clinicians to design and conduct high-quality TDM studies.

Original languageEnglish
Pages (from-to)1008-1016
Number of pages9
JournalClinical Microbiology and Infection
Volume26
Issue number8
Early online date21-Mar-2020
Publication statusPublished - Aug-2020

    Keywords

  • Drug exposure, Personalized dosing study design, Pharmacodynamics, Pharmacokinetics, Randomized controlled trials, Therapeutic drug monitoring, CRITICALLY-ILL PATIENTS, PROFICIENCY TESTING PROGRAM, QUASI-EXPERIMENTAL DESIGNS, BETA-LACTAM ANTIBIOTICS, EPITHELIAL LINING FLUID, QUALITY-CONTROL PROGRAM, POPULATION PHARMACOKINETICS, COST-EFFECTIVENESS, VANCOMYCIN, TUBERCULOSIS

ID: 121091252